1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Diaceutics PLC
  6. News
  7. Summary
    DXRX   GB00BJQTGV64

DIACEUTICS PLC

(DXRX)
  Report
Delayed London Stock Exchange  -  05/17 11:35:05 am EDT
110.50 GBX   -1.78%
05/05Diaceutics Bags $1 Million Data Subscription Deal With Pharma Company
MT
05/05Diaceutics PLC Secures Five-Year, Multi-Product Subscription Contract with A Top 30 Global Pharma Company
CI
03/23TRANSCRIPT : Diaceutics PLC, 2021 Earnings Call, Mar 23, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Diaceutics PLC Secures Five Year Subscription Contract with A Top Five Global Life Sciences Company

12/14/2021 | 02:00am EDT

Diaceutics PLC announced that it has secured a five year subscription contract with a top five global life sciences company, a global leader in diagnostics, to deliver customised data insights via the DXRX platform. The total contract value is in excess of $1 million spread across five years and subject to milestones in year 1 and year 3. This contract demonstrates the demand for customised real-world data to support sales and marketing initiatives for leading life science companies, the applicability of the Company's offering to businesses outside of its core pharma customer base, and supports the move towards enhanced subscription-based revenues, a key strategy for the Company going forward. The contract will see Diaceutics deliver real-world data and insights on the demand for biomarkers customised to the client's needs across a number of diseases. This information will help the customer to identify important biomarker adoption trends and gaps which can support the commercialisation of new and existing diagnostics. The data will be supplied from DXRX, the world's first diagnostic commercialisation platform for Precision Medicine, which uses machine learning to integrate output of real-world, real time diagnostic testing data from a global network of laboratories.


ę S&P Capital IQ 2021
All news about DIACEUTICS PLC
05/05Diaceutics Bags $1 Million Data Subscription Deal With Pharma Company
MT
05/05Diaceutics PLC Secures Five-Year, Multi-Product Subscription Contract with A Top 30 Glo..
CI
03/23TRANSCRIPT : Diaceutics PLC, 2021 Earnings Call, Mar 23, 2022
CI
03/23Earnings Flash (DXRX.L) DIACEUTICS Posts FY21 EPS GBX0.66
MT
03/23Earnings Flash (DXRX.L) DIACEUTICS Posts FY21 Revenue GBP13.9M
MT
03/22Diaceutics PLC Reports Earnings Results for the Full Year Ended December 31, 2021
CI
03/18Diaceutics' New CFO Assumes Role
MT
03/18Diaceutics Announces Executive Changes
CI
02/14Diaceutics Wins $3 Million Data Subscription Contract with Life Sciences Group
MT
02/14Diaceutics PLC Secures Three Year Data Subscription Contract with A Global Life Science..
CI
More news
Financials
Sales 2022 16,6 M 20,7 M 20,7 M
Net income 2022 2,60 M 3,24 M 3,24 M
Net cash 2022 17,8 M 22,2 M 22,2 M
P/E ratio 2022 36,6x
Yield 2022 -
Capitalization 93,2 M 116 M 116 M
EV / Sales 2022 4,54x
EV / Sales 2023 3,56x
Nbr of Employees 133
Free-Float 48,9%
Chart DIACEUTICS PLC
Duration : Period :
Diaceutics PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 110,50 GBX
Average target price 200,00 GBX
Spread / Average Target 81,0%
EPS Revisions
Managers and Directors
Peter Keeling Chief Executive Officer & Director
Nick Roberts Chief Financial Officer & Director
Deborah Lee Davis Non-Executive Chairman
Johnny Rice Director-Information Technology
Julie Browne Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
DIACEUTICS PLC10.29%116
CLARIVATE PLC-39.29%9 604
WNS (HOLDINGS) LIMITED-19.32%3 477
VERRA MOBILITY CORPORATION-2.79%2 343
JMDC INC.-41.49%2 197
COMPUTER AGE MANAGEMENT SERVICES LIMITED-17.64%1 358